Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-02-04

FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for oxcarbazepine submitted by Amneal Pharmaceuticals LLC, expanding the regulatory authorization for this generic a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)